Skip to content
CPSCHome & outdoor

Kramer Laboratories Recalls Safetussin Max Strength Multi-Symptom Cough, Cold and Flu Blister Packs Due to Risk of Child Poisoning; Violation of Federal Regulation for Child Resistant Packaging

CPSC recall 25223 ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

What the agency says to do

Refund

Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.
Text from CPSC, unedited.

Contact (CPSC): Kramer Laboratories at 800-824-4894 Monday through Friday 8 a.m. to 5 p.m. ET, e-mail at kramerlabs@emersongroup.com, or online at https://safetussin.com/recall for more information.

Note from Recalls Watch, not agency text

Why it was recalled

The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.
Text from CPSC, unedited.

Incidents and injuries (CPSC): None reported

The recalled product

This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.
Text from CPSC, unedited.
  • Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets blister packs

    Quantity
    About 14,250

Where it was sold (CPSC): HEB, Harris-Teeter and other regional grocery stores and independently owned pharmacies nationwide from July 2024 through March 2025 for about $11.

Recalled Safetussin Max Strength Multi-Symptom Cough, Cold and Flu, 24-count caplets
Recalled Safetussin Max Strength Multi-Symptom Cough, Cold and Flu, 24-count caplets Photo: CPSC.

Source

Issued by
U.S. Consumer Product Safety Commission
Firm
Kramer Laboratories

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Month: April 2025, Week 2025-W15. Browse more home & outdoor recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

CPSC states: “The Safetussin over-the-counter cold medicine contains acetaminophen, which must be in child-resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child-resistant as a tablet can be pushed through the foil, posing a risk of poisoning if the contents are swallowed by young children.”

What should owners do?

CPSC states: “Consumers should immediately secure the product out of the sight and reach of children and contact Kramer Laboratories for information on how to return or dispose of the product for a full refund. Only the packaging is being recalled, not the medicine itself, but both should be disposed.”

Which products are included?

CPSC states: “This recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. They are labeled with "Safetussin," "Multi-Symptom," "Cough, Cold & Flu" and "Safe for adults with High Blood Pressure, Diabetes." They were sold in a blue, orange and red cardboard box with the drug facts label on the back.”

When was this recall published?

CPSC published recall 25223 on April 10, 2025.